About Norgen Biotek
Founded in 1998, Norgen Biotek Corp. develops technologies for the collection, preservation, purification and analysis of nucleic acids, proteins and extracellular vesicles from a wide range of biological samples. The company’s proprietary resin and matrix platform technologies support the isolation of RNA, including microRNA, DNA, proteins and exosomes from challenging sample types such as blood, urine, saliva, stool, environmental samples and plant tissues. These technologies enable researchers to obtain high-quality analytes for downstream molecular biology workflows, supporting applications in genomics, transcriptomics, microbiome research, liquid biopsy, biomarker discovery, infectious disease research and molecular diagnostics.
Norgen Biotek offers an extensive portfolio of sample collection and preservation devices, nucleic acid and protein purification kits, exosome isolation products, multi-analyte extraction kits, pathogen detection assays, NGS library preparation kits and quantification assays. Its product range includes proprietary RNA purification technologies based on Silicon Carbide (SiC) chemistry, as well as workflows for circulating nucleic acids, exosomal RNA, microbiome analysis and viral vector purification. The company also provides sequencing and isolation services, contract manufacturing and OEM support for research and diagnostic development.
Europa Biosite’s subsidiaries distribute for Norgen Biotek in Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden and Switzerland.